PLAINSBORO, N.J., Sept. 29, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the release of a smaller configuration of the innovative Accell Evo3(R) Demineralized Bone Matrix. Originally introduced as a bone void filler for large orthopedic reconstructive procedures, the new smaller size of Accell Evo3(R) expands the possible application options for the surgeon, particularly in procedures where smaller amounts of demineralized bone matrix are required.